478 related articles for article (PubMed ID: 30853123)
1. Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases.
Braga BP; Prieto-González S; Hernández-Rodríguez J
Med Clin (Barc); 2019 Jun; 152(12):502-507. PubMed ID: 30853123
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of
Dunbar A; Schauwvlieghe A; Algoe S; van Hellemond JJ; Reynders M; Vandecasteele S; Boelens J; Depuydt P; Rijnders B
Front Cell Infect Microbiol; 2020; 10():224. PubMed ID: 32500040
[No Abstract] [Full Text] [Related]
4. Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases.
Baulier G; Issa N; Gabriel F; Accoceberry I; Camou F; Duffau P
Clin Exp Rheumatol; 2018; 36(3):490-493. PubMed ID: 29533748
[TBL] [Abstract][Full Text] [Related]
5. Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis.
Amber KT; Lamberts A; Solimani F; Agnoletti AF; Didona D; Euverman I; Cozzani E; Yueh LH; Di Zenzo G; Leshem YA; Mimouni D; Hertl M; Horvath B
JAMA Dermatol; 2017 Nov; 153(11):1137-1141. PubMed ID: 28854309
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose glucocorticoid.
Chew LC; Maceda-Galang LM; Tan YK; Chakraborty B; Thumboo J
J Clin Rheumatol; 2015 Mar; 21(2):72-5. PubMed ID: 25710857
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
Green H; Paul M; Vidal L; Leibovici L
Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
[TBL] [Abstract][Full Text] [Related]
8. Opinions on Pneumocystis jirovecii prophylaxis in autoimmune neuromuscular disorders.
Claytor B; Li Y
Muscle Nerve; 2022 Mar; 65(3):278-283. PubMed ID: 34952994
[TBL] [Abstract][Full Text] [Related]
9. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
10. [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].
Özkoç S; Bayram Delibaş S
Mikrobiyol Bul; 2015 Apr; 49(2):221-30. PubMed ID: 26167822
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases.
Ghembaza A; Vautier M; Cacoub P; Pourcher V; Saadoun D
Chest; 2020 Dec; 158(6):2323-2332. PubMed ID: 32502592
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.
Mori S; Sugimoto M
Rheumatology (Oxford); 2012 Dec; 51(12):2120-30. PubMed ID: 23001613
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of Pneumocystis jirovecii Infection and Colonization in Immunocompromised Patients with Pneumonia].
Gülbudak H; Öztürk C; Kuyugöz S; Tezcan Ülger S
Mikrobiyol Bul; 2020 Oct; 54(4):583-595. PubMed ID: 33107287
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway.
Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
BMC Infect Dis; 2021 Jul; 21(1):659. PubMed ID: 34233631
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan.
Weng CT; Liu MF; Weng MY; Lee NY; Wang MC; Lin WC; Ou CY; Lai WW; Hsu SC; Chao SC; Chung TJ; Lee CT; Shieh CC; Wang JY; Wang CR
J Clin Rheumatol; 2013 Aug; 19(5):252-8. PubMed ID: 23872548
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: Usefulness of lymphocyte subtyping.
Li Y; Ghannoum M; Deng C; Gao Y; Zhu H; Yu X; Lavergne V
Int J Infect Dis; 2017 Apr; 57():108-115. PubMed ID: 28223177
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
Schmajuk G; Jafri K; Evans M; Shiboski S; Gianfrancesco M; Izadi Z; Patterson SL; Aggarwal I; Sarkar U; Dudley RA; Yazdany J
Semin Arthritis Rheum; 2019 Jun; 48(6):1087-1092. PubMed ID: 30449650
[TBL] [Abstract][Full Text] [Related]
19. A case of new-onset rheumatoid vasculitis becoming evident in the course of treatment for Pneumocystis jirovecii pneumonia.
Ikuma D; Yokota K; Sato K; Mimura T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):78-82. PubMed ID: 28539558
[TBL] [Abstract][Full Text] [Related]
20. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
